These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34906510)

  • 41. Variants of Unknown Significance in Maturity-Onset Diabetes of the Young: High Rate of Conundrum Resolution via Variants of Unknown Significance Reanalysis.
    Alarcon G; Maston GA; Hoffman CA; Posey JE; Redondo MJ; Tosur M
    Horm Res Paediatr; 2024 May; ():1-8. PubMed ID: 38806007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK).
    Loong L; Garrett A; Allen S; Choi S; Durkie M; Callaway A; Drummond J; Burghel GJ; Robinson R; Torr B; Berry IR; Wallace AJ; Eccles DM; Ellard S; Baple E; Evans DG; Woodward ER; Kulkarni A; Lalloo F; Tischkowitz M; Lucassen A; Hanson H; Turnbull C;
    Genet Med; 2022 Sep; 24(9):1867-1877. PubMed ID: 35657381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?
    Kwong A; Ho CYS; Shin VY; Au CH; Chan TL; Ma ESK
    BMC Med Genomics; 2022 May; 15(1):122. PubMed ID: 35641994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population.
    Li D; Shi Y; Li A; Cao D; Su H; Yang H; Zhi Q; Yang Y; Lan Z; Zhou T; You X; Hu G
    Breast Cancer; 2020 Nov; 27(6):1158-1167. PubMed ID: 32566972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Spliceogenic Variants beyond Canonical GT-AG Splice Sites in Hereditary Cancer Genes.
    Dragoš VŠ; Strojnik K; Klančar G; Škerl P; Stegel V; Blatnik A; Banjac M; Krajc M; Novaković S
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preconception carrier screening yield: effect of variants of unknown significance in partners of carriers with clinically significant variants.
    Fridman H; Behar DM; Carmi S; Levy-Lahad E
    Genet Med; 2020 Mar; 22(3):646-653. PubMed ID: 31624327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
    Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
    Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three Newly Recognized Likely Pathogenic Gene Variants Associated with Hereditary Transthyretin Amyloidosis.
    Patel JK; Rosen AM; Chamberlin A; Feldmann B; Antolik C; Zimmermann H; Johnston T; Narayana A
    Neurol Ther; 2022 Dec; 11(4):1595-1607. PubMed ID: 35933469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reclassification of the
    Grant AR; Hemphill SE; Vincent LM; Rehm HL
    Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 29945942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient goals, motivations, and attitudes in a patient-driven variant reclassification study.
    Tsai GJ; Garrett LT; Makhnoon S; Bowen DJ; Burke W; Shirts BH
    J Genet Couns; 2019 Jun; 28(3):558-569. PubMed ID: 31163102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Good performance of the criteria of American College of Medical Genetics and Genomics/Association for Molecular Pathology in prediction of pathogenicity of genetic variants causing thoracic aortic aneurysms and dissections.
    Ponińska JK; Bilińska ZT; Truszkowska G; Michalak E; Podgórska A; Stępień-Wojno M; Chmielewski P; Lutyńska A; Płoski R
    J Transl Med; 2022 Jan; 20(1):42. PubMed ID: 35078481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prioritizing variants of uncertain significance for reclassification using a rule-based algorithm in inherited retinal dystrophies.
    Iancu IF; Avila-Fernandez A; Arteche A; Trujillo-Tiebas MJ; Riveiro-Alvarez R; Almoguera B; Martin-Merida I; Del Pozo-Valero M; Perea-Romero I; Corton M; Minguez P; Ayuso C
    NPJ Genom Med; 2021 Feb; 6(1):18. PubMed ID: 33623043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variant curation and interpretation in hereditary cancer genes: An institutional experience in Latin America.
    Manotas MC; Rivera AL; Sanabria-Salas MC
    Mol Genet Genomic Med; 2023 May; 11(5):e2141. PubMed ID: 36905130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.
    Fortuno C; Cops EJ; Davidson AL; Hadler J; Innella G; McKenzie ME; Parsons M; Campbell AM; Dubowsky A; Fargas V; Field MJ; Mar Fan HG; Nichols CB; Poplawski NK; Warwick L; Williams R; Beshay V; Edwards C; Johns A; McPhillips M; Kumar VS; Scott R; Williams M; Scott H; James PA; Spurdle AB
    Eur J Hum Genet; 2024 Dec; 32(12):1632-1639. PubMed ID: 39402389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study.
    Morales A; Kinnamon DD; Jordan E; Platt J; Vatta M; Dorschner MO; Starkey CA; Mead JO; Ai T; Burke W; Gastier-Foster J; Jarvik GP; Rehm HL; Nickerson DA; Hershberger RE; ;
    Circ Genom Precis Med; 2020 Apr; 13(2):e002480. PubMed ID: 32160020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
    Eccles DM; Mitchell G; Monteiro AN; Schmutzler R; Couch FJ; Spurdle AB; Gómez-García EB;
    Ann Oncol; 2015 Oct; 26(10):2057-65. PubMed ID: 26153499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reinterpretation of common pathogenic variants in ClinVar revealed a high proportion of downgrades.
    Xiang J; Yang J; Chen L; Chen Q; Yang H; Sun C; Zhou Q; Peng Z
    Sci Rep; 2020 Jan; 10(1):331. PubMed ID: 31942019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is 'likely pathogenic' really 90% likely? Reclassification data in ClinVar.
    Harrison SM; Rehm HL
    Genome Med; 2019 Nov; 11(1):72. PubMed ID: 31752965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrospective analysis and reclassification of DYSF variants in a large French series of dysferlinopathy patients.
    Charnay T; Blanck V; Cerino M; Bartoli M; Riccardi F; Bonello-Palot N; Pécheux C; Nguyen K; Lévy N; Gorokhova S; Krahn M
    Genet Med; 2021 Aug; 23(8):1574-1577. PubMed ID: 33927379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical implications of conflicting variant interpretations in the cancer genetics clinic.
    Zukin E; Culver JO; Liu Y; Yang Y; Ricker CN; Hodan R; Sturgeon D; Kingham K; Chun NM; Rowe-Teeter C; Singh K; Zell JA; Ladabaum U; McDonnell KJ; Ford JM; Parmigiani G; Braun D; Kurian AW; Gruber SB; Idos GE
    Genet Med; 2023 Jul; 25(7):100837. PubMed ID: 37057674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.